Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

NCT01598454 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroblastoma
Ewing's Sarcoma
Wilm's Tumor
Retinoblastoma
Glioma

Interventions

DRUG: racotumomab

Sponsor

Laboratorio Elea Phoenix S.A.

Collaborators

[object Object]